Trial intelligence / Profile preview

siSPARC vs siSPARC + siLR4A Microneedle Patches for Post-surgical Scars

NCT06138964Phase 2Recruiting

Sponsor
National Skin Centre
Start
Nov 2023
Primary completion
Nov 2024
Modality
Conjugated siRNA, Chemically Modified siRNA
Countries
1
01

Overview

A Phase 2 trial of siSPARC in surgical scar, keloid, sponsored by National Skin Centre. Started Nov 2023; status: recruiting.

02

Drugs

siSPARC
03

Conditions

surgical scarkeloid

Beyond the preview

Go deeper on NCT06138964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06138964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call